Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092238768> ?p ?o ?g. }
- W2092238768 endingPage "2838" @default.
- W2092238768 startingPage "2830" @default.
- W2092238768 abstract "Abstract Treatment of different human leukemia cell variants with the anthracycline adriamycin was associated with a rapid activation of the proteasome. Thus, proliferating U937, TUR, and retrodifferentiated U937 cells exhibited a 4.3-fold, 5.8-fold, and 4.3-fold proteasome activation within 15 minutes after adriamycin treatment, respectively. In contrast, little if any proteasome activation was detectable in a growth-arrested differentiated U937 population following adriamycin treatment. Further analysis of this mechanism revealed a significant reduction of adriamycin-induced proteasome activity after inhibition of poly(ADP-ribose) polymerase (PARP) by 3-aminobenzamide (3-ABA) in the proliferating leukemic cell types. These findings suggested that PARP is involved in the regulation of drug-induced proteasome activation. Indeed, anti-PARP immunoprecipitation experiments of adriamycin-treated cells revealed increasing levels of coprecipitated, enzymatically active proteasome particularly in the proliferating cell variants in contrast to the differentiated U937 cells, with a maximum after 15 minutes, and sensitivity to PARP inhibition by 3-ABA. The specific role of the PARP was investigated in U937 and TUR cell clones stably transfected with a constitutively active antisense PARP (asPARP) vector. Thus, asPARP-TUR cells developed a 25-fold increased sensitivity to adriamycin treatment. Furthermore, we investigated leukemic blasts isolated from acute myelogenous leukemia patients and obtained a similarly enhanced proteasome activity after adriamycin treatment, which was dependent on the PARP and thus could be coprecipitated with anti-PARP antibodies. Transient transfection of leukemic blasts with the asPARP vector significantly reduced the adriamycin-induced proteasome activation. These data suggest that the PARP-associated nuclear proteasome activation represents a potential target within chemotherapeutic defense mechanisms developed by leukemia cells." @default.
- W2092238768 created "2016-06-24" @default.
- W2092238768 creator A5006029730 @default.
- W2092238768 creator A5025328131 @default.
- W2092238768 creator A5030526585 @default.
- W2092238768 creator A5030775003 @default.
- W2092238768 creator A5036956314 @default.
- W2092238768 date "2001-05-01" @default.
- W2092238768 modified "2023-10-12" @default.
- W2092238768 title "Regulation of the nuclear proteasome activity in myelomonocytic human leukemia cells after adriamycin treatment" @default.
- W2092238768 cites W1503356929 @default.
- W2092238768 cites W1529957398 @default.
- W2092238768 cites W1531318383 @default.
- W2092238768 cites W1566636169 @default.
- W2092238768 cites W1585518597 @default.
- W2092238768 cites W1600112653 @default.
- W2092238768 cites W1632979324 @default.
- W2092238768 cites W1821222826 @default.
- W2092238768 cites W183120241 @default.
- W2092238768 cites W1882486138 @default.
- W2092238768 cites W1964413925 @default.
- W2092238768 cites W1976582166 @default.
- W2092238768 cites W1981189001 @default.
- W2092238768 cites W1990316794 @default.
- W2092238768 cites W1997483413 @default.
- W2092238768 cites W1998008670 @default.
- W2092238768 cites W2001010253 @default.
- W2092238768 cites W2001692018 @default.
- W2092238768 cites W2008418226 @default.
- W2092238768 cites W2012960886 @default.
- W2092238768 cites W2033761616 @default.
- W2092238768 cites W2042472240 @default.
- W2092238768 cites W2044320834 @default.
- W2092238768 cites W2049033337 @default.
- W2092238768 cites W2052725995 @default.
- W2092238768 cites W2053273074 @default.
- W2092238768 cites W2054248299 @default.
- W2092238768 cites W2057557981 @default.
- W2092238768 cites W2062124441 @default.
- W2092238768 cites W2074823657 @default.
- W2092238768 cites W2077868873 @default.
- W2092238768 cites W2078082552 @default.
- W2092238768 cites W2086031969 @default.
- W2092238768 cites W2089666635 @default.
- W2092238768 cites W2092629964 @default.
- W2092238768 cites W2107613496 @default.
- W2092238768 cites W2137281279 @default.
- W2092238768 cites W2146501567 @default.
- W2092238768 cites W2161401873 @default.
- W2092238768 cites W2178503716 @default.
- W2092238768 cites W2331470056 @default.
- W2092238768 cites W4236309725 @default.
- W2092238768 cites W73359563 @default.
- W2092238768 doi "https://doi.org/10.1182/blood.v97.9.2830" @default.
- W2092238768 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11313278" @default.
- W2092238768 hasPublicationYear "2001" @default.
- W2092238768 type Work @default.
- W2092238768 sameAs 2092238768 @default.
- W2092238768 citedByCount "35" @default.
- W2092238768 countsByYear W20922387682012 @default.
- W2092238768 countsByYear W20922387682013 @default.
- W2092238768 countsByYear W20922387682014 @default.
- W2092238768 countsByYear W20922387682018 @default.
- W2092238768 countsByYear W20922387682022 @default.
- W2092238768 crossrefType "journal-article" @default.
- W2092238768 hasAuthorship W2092238768A5006029730 @default.
- W2092238768 hasAuthorship W2092238768A5025328131 @default.
- W2092238768 hasAuthorship W2092238768A5030526585 @default.
- W2092238768 hasAuthorship W2092238768A5030775003 @default.
- W2092238768 hasAuthorship W2092238768A5036956314 @default.
- W2092238768 hasBestOaLocation W20922387681 @default.
- W2092238768 hasConcept C108634530 @default.
- W2092238768 hasConcept C153911025 @default.
- W2092238768 hasConcept C181199279 @default.
- W2092238768 hasConcept C182979987 @default.
- W2092238768 hasConcept C203014093 @default.
- W2092238768 hasConcept C27740335 @default.
- W2092238768 hasConcept C2778461978 @default.
- W2092238768 hasConcept C502942594 @default.
- W2092238768 hasConcept C54009773 @default.
- W2092238768 hasConcept C54355233 @default.
- W2092238768 hasConcept C55493867 @default.
- W2092238768 hasConcept C62112901 @default.
- W2092238768 hasConcept C81885089 @default.
- W2092238768 hasConcept C82381507 @default.
- W2092238768 hasConcept C86803240 @default.
- W2092238768 hasConcept C95444343 @default.
- W2092238768 hasConceptScore W2092238768C108634530 @default.
- W2092238768 hasConceptScore W2092238768C153911025 @default.
- W2092238768 hasConceptScore W2092238768C181199279 @default.
- W2092238768 hasConceptScore W2092238768C182979987 @default.
- W2092238768 hasConceptScore W2092238768C203014093 @default.
- W2092238768 hasConceptScore W2092238768C27740335 @default.
- W2092238768 hasConceptScore W2092238768C2778461978 @default.
- W2092238768 hasConceptScore W2092238768C502942594 @default.
- W2092238768 hasConceptScore W2092238768C54009773 @default.
- W2092238768 hasConceptScore W2092238768C54355233 @default.
- W2092238768 hasConceptScore W2092238768C55493867 @default.